Double-blind, randomized controlled trial of therapeutic plasma exchanges vs sham exchanges in moderate-to-severe relapses of multiple sclerosis.

Date publication

mai 2020

Journal

Journal of clinical apheresis

Auteurs

Membres identifiés du Cancéropôle Est :
Pr DE SEZE Jérôme

Tous les auteurs :
Brochet B, Deloire M, Germain C, Ouallet JC, Wittkop L, Dulau C, Perez P, Thevenot F, De Sèze J, Zéphir H, Vermersch P, Pittion S, Debouverie M, Laplaud DA, Clavelou P, Ruet A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32369661

Résumé

No randomized controlled clinical trial of therapeutic plasma exchanges (TPE) has yet been performed for moderate-to-severe relapses of multiple sclerosis (MS).

Mots clés

apheresis, central nervous system, clinical trial, demyelinating disease, disability, therapeutic plasma exchanges

Référence

J Clin Apher. 2020 May 5;: